Co Diagnostics Stock Price - CODX

0.01 (0.06%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Co Diagnostics Inc CODX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.88 -5.22% 15.98 15.118 16.4529 16.415 16.86 00:00:01
Bid Price Ask Price Spread Spread % News
15.80 16.00 0.20 1.25% 4 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
16,624 2,412,893 $ 15.83 $ 38,197,865 9,658,220 0.694 - 31.40
Last Trade Time Type Quantity Stock Price Currency
19:57:38 50 $ 15.99 USD

Co Diagnostics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 438.76M 27.46M 25.18M $ 214.97k $ - -0.36 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Co Diagnostics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CODX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week17.1018.3715.11817.331,976,104-1.12-6.55%
1 Month14.7431.4014.6019.708,422,5901.248.41%
3 Months11.7631.406.8114.487,832,5354.2235.88%
6 Months1.0031.400.8810.958,523,05814.981,498.0%
1 Year0.829531.400.69410.294,571,90915.151,826.46%
3 Years6.0031.400.6949.471,813,1179.98166.33%
5 Years6.0031.400.6949.471,813,1179.98166.33%

Co Diagnostics Description

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company's diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests.

Your Recent History
Co Diagnos..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.